Ginkgo Bioworks Holdings (DNA) Current Assets (2020 - 2026)

Ginkgo Bioworks Holdings has reported Current Assets for 7 years, with the latest figure at $410.0 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets fell 27.38% year-over-year to $410.0 million; the trailing twelve-month figure through Mar 2026 stood at $410.0 million (down 27.38% YoY), and the FY2025 full-year result was $471.8 million, down 21.72% from the prior year.
• Current Assets for Q1 2026 stood at $410.0 million, down from $471.8 million in the prior quarter.
• The five-year high for Current Assets was $1.7 billion in Q1 2022, with the low at $410.0 million in Q1 2026.
• Historically, Current Assets has averaged $961.1 million across 5 years, with a median of $903.0 million in 2024.
• Annual changes were most pronounced in 2022 — Current Assets surged 165261.75% — and 2024, when it plunged 41.98%.
• Ginkgo Bioworks Holdings' Current Assets stood at $1.5 billion in 2022, then tumbled by 30.92% to $1.0 billion in 2023, then sank by 39.83% to $602.7 million in 2024, then fell by 21.72% to $471.8 million in 2025, then decreased by 13.12% to $410.0 million in 2026.
• The last three Current Assets figures came in at $410.0 million (Q1 2026), $471.8 million (Q4 2025), and $506.1 million (Q3 2025), per Business Quant data.